D
Didier Lebrec
Researcher at Beaujon Hospital
Publications - 7
Citations - 1892
Didier Lebrec is an academic researcher from Beaujon Hospital. The author has contributed to research in topics: Cirrhosis & Phenylalanine. The author has an hindex of 4, co-authored 7 publications receiving 1840 citations. Previous affiliations of Didier Lebrec include Ferring Pharmaceuticals.
Papers
More filters
Journal ArticleDOI
Clinical classification of pulmonary hypertension
Gérald Simonneau,Nazzareno Galiè,Lewis J. Rubin,David Langleben,Werner Seeger,Guido Domenighetti,Simon Gibbs,Didier Lebrec,Rudolf Speich,Maurice Beghetti,Stuart Rich,Alfred P. Fishman +11 more
TL;DR: The growth of understanding of the pulmonary hypertensive diseases that has enabled the development of a clinical classification oriented towards prevention and treatment is traced.
Journal ArticleDOI
Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndrome.
Benjamin Sztrymf,Jean-Marie Libert,Christine Mougeot,Didier Lebrec,Michel Mazmanian,Marc Humbert,Philippe Hervé +6 more
TL;DR: The hypothesis was tested that the cirrhotic rats with bacterial translocation had higher TNF‐α production, higher level of sequestration of macrophages in pulmonary vessels, and increased incidence and severity of hepatopulmonary syndrome.
Journal ArticleDOI
Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats
TL;DR: The aim of this study was to evaluate the effects of modulating aortic and superior mesenteric arteries (SMA) iNOS on arterial eNOS activity and expression in rats with cirrhosis.
Patent
Improved protocol for paracentesis
Didier Lebrec,Richard Moreau +1 more
TL;DR: In this paper, an improved method for the treatment of hypovolaemia or hypotension associated with therapeutic paracentesis is described, which is characterized by the use of a peptide according to general formulae (1) or a salt thereof.
Patent
Protocol for paracentesis
Didier Lebrec,Richard Moreau +1 more
TL;DR: In this paper, an improved method for the treatment of hypovolaemia or hypotension associated with therapeutic paracentesis was proposed, which is characterised by the use of a peptide according to general formulae (I) or a salt thereof, wherin Asn, Cys, Gln, Gly, Phe and Pro represent the amino acid residues asparigine, cysteine, glutamine, glycine, phenylalanine and proline respectively.